U.S. Markets open in 6 hrs 16 mins

Acusphere, Inc. (ACUS)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.04+0.00 (+5.26%)
At close: 3:41PM EDT
People also watch
ADLSEPIXEMISARQLBDSI

Acusphere, Inc.

99 Hayden Avenue
Suite 385
Lexington, MA 02421
United States
617-648-8800
http://www.acusphere.com

SectorHealthcare
IndustryDrug Manufacturers - Other
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Dr. William I. Ramage D.PhilChief Devel. Officer225.09kN/A63
Amounts are as of December 31, 2000 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Lexington, Massachusetts.

Corporate Governance

Acusphere, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.